Fortress Biotech FBIOP
NASDAQ FBIOP
$18.30 +0.03 (+0.16%)
As of: Aug 21, 2026 · 3:33 PM EDT

Fortress Biotech, Inc. (FBIOP) Current Deferred Revenue (2016 - 2023)

Fortress Biotech (FBIOP) posted quarterly Current Deferred Revenue of $547000.0 for Q1 2023, down 73.11% year-over-year from $2.0 million in Q1 2022, and down 24.86% quarter-over-quarter from $728000.0 in Q4 2022.

Fortress Biotech, Inc. (FBIOP) Current Deferred Revenue (2016 - 2023) Analysis & Trends

Fortress Biotech's Current Deferred Revenue history runs 6 years deep, the most recent figure standing at $547000.0 for Q1 2023.

  • In Q1 2023, Current Deferred Revenue fell 73.11% year-over-year to $547000.0; the TTM figure through Mar 2023 stood at $547000.0 (down 73.11% YoY), while the FY2022 annual figure was $728000.0, down 72.12% from the prior year.
  • Current Deferred Revenue for Q1 2023 stood at $547000.0, down from $728000.0 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $7.2 million in Q1 2021, with the low at $547000.0 in Q1 2023.
  • The 3-year median for Current Deferred Revenue is $2.0 million (2022), against an average of $2.6 million.
  • The sharpest annual moves came in 2022 and 2023: Current Deferred Revenue plunged 67.41% in 2022, then slumped 73.11% in 2023.
  • Fortress Biotech's Current Deferred Revenue stood at $2.6 million in 2021, then plunged by 72.12% to $728000.0 in 2022, then fell by 24.86% to $547000.0 in 2023.
  • Business Quant data shows FBIOP's Current Deferred Revenue at $547000.0 in Q1 2023, $728000.0 in Q4 2022, and $1.1 million in Q3 2022.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2023 547,000.00
Dec 31, 2022 728,000.00
Sep 30, 2022 1.09 Mn
Jun 30, 2022 1.46 Mn
Mar 31, 2022 2.03 Mn
Dec 31, 2021 2.61 Mn
Sep 30, 2021 3.35 Mn
Jun 30, 2021 4.80 Mn
Mar 31, 2021 7.20 Mn
Sep 30, 2018 155,000.00
Jun 30, 2018 681,000.00
Mar 31, 2018 690,000.00
Sep 30, 2017 500,000.00
Jun 30, 2017 891,000.00
Mar 31, 2017 943,000.00
Dec 31, 2016 995,000.00
Sep 30, 2016 300,000.00